Form 4 Tracker
Annexon, Inc.
ANNX

28 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 13, 2026Aug 13 7:34 PMWIGGANS THOMAS G
Proposed Sale
2,000$5.30$10.6K

View →

Jul 15, 2026Jul 15 8:19 PMWIGGANS THOMAS G
Proposed Sale
2,000$6.32$12.6K

View →

Jul 14, 2026Jul 14 5:56 PMWIGGANS THOMAS G
Proposed Sale
1,000$5.61$5.6K

View →

May 28, 2026May 29 9:21 PMSatter Muneer ADirector
Purchase
613,497$5.41$3.3M10,342,134(I)

View →

May 11, 2026May 13 8:30 PMWilliam H. CarsonDirector
Purchase
8,000$5.78$46.2K78,405(D)

View →

Apr 10, 2026Apr 14 8:16 PMWilliam H. CarsonDirector
Purchase
8,000$6.20$49.6K70,405(D)

View →

Mar 10, 2026Mar 12 8:31 PMWilliam H. CarsonDirector
Purchase
8,000$5.67$45.4K62,405(D)

View →

Mar 2, 2026Mar 4 9:30 PMJamie DananbergCHIEF MEDICAL OFFICER
Sale
5,820$5.43$31.6K123,582(D)

View →

Mar 2, 2026Mar 4 9:30 PMMichael OverdorfEVP & CHIEF BUSINESS OFFICER
Sale
4,339$5.42$23.5K182,625(D)

View →

Mar 2, 2026Mar 4 9:30 PMTed YednockEVP & CHIEF INNOVATION OFFICER
Sale
5,566$5.42$30.2K154,161(D)

View →

Mar 2, 2026Mar 4 9:30 PMDean Richard ArtisEVP & CHIEF SCIENTIFIC OFFICER
Sale
5,894$5.43$32.0K180,093(D)

View →

Mar 2, 2026Mar 4 9:30 PMJennifer LewEVP & CHIEF FINANCIAL OFFICER
Sale
5,565$5.42$30.2K170,700(D)

View →

Mar 2, 2026Mar 2 10:05 PMYednock Ted
Proposed Sale
5,566$5.42$30.2K

View →

Mar 2, 2026Mar 2 9:41 PMARTIS DEAN RICHARD
Proposed Sale
5,894$5.43$32.0K

View →

Mar 2, 2026Mar 2 9:16 PMOverdorf Michael
Proposed Sale
4,339$5.42$23.5K

View →

Mar 2, 2026Mar 2 9:05 PMDananberg Jamie
Proposed Sale
5,820$5.43$31.6K

View →

Mar 2, 2026Mar 2 9:02 PMLew Jennifer
Proposed Sale
5,565$5.42$30.2K

View →

Feb 18, 2026Feb 20 9:30 PMJamie DananbergCHIEF MEDICAL OFFICER
Sale
5,290$5.10$27.0K73,152(D)

View →

Feb 18, 2026Feb 20 9:30 PMJennifer LewEVP & CHIEF FINANCIAL OFFICER
Sale
7,851$5.11$40.1K113,765(D)

View →

Feb 18, 2026Feb 20 9:30 PMDean Richard ArtisEVP & CHIEF SCIENTIFIC OFFICER
Sale
5,290$5.10$27.0K123,487(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 10, 2026Aug 12 10:10 PMBlumenkranz Mark S.Director
Grant/Award
175,000$5.39175,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMWilliam D. WaddillDirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMSatter Muneer ADirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMWilliam A Jones JRDirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMBettina M. CockroftDirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMJung ChoiDirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMWilliam H. CarsonDirector
Grant/Award
65,000$4.7065,000(D)

View →

Jun 11, 2026Jun 15 8:15 PMTed YednockEVP & CHIEF INNOVATION OFFICER
Option Exercise
30,646$1.850(D)

View →

Feb 19, 2026Feb 24 12:11 AMDouglas LoveDirector, PRESIDENT AND CEO
Grant/Award
1,250,000$5.101,250,000(D)

View →

Feb 19, 2026Feb 24 12:09 AMJamie DananbergCHIEF MEDICAL OFFICER
Grant/Award
225,000$5.10225,000(D)

View →

Feb 19, 2026Feb 24 12:08 AMMichael OverdorfEVP & CHIEF BUSINESS OFFICER
Grant/Award
250,000$5.10250,000(D)

View →

Feb 19, 2026Feb 24 12:07 AMDean Richard ArtisEVP & CHIEF SCIENTIFIC OFFICER
Grant/Award
250,000$5.10250,000(D)

View →

Feb 19, 2026Feb 24 12:05 AMTed YednockEVP & CHIEF INNOVATION OFFICER
Grant/Award
250,000$5.10250,000(D)

View →

Feb 19, 2026Feb 24 12:03 AMJennifer LewEVP & CHIEF FINANCIAL OFFICER
Grant/Award
250,000$5.10250,000(D)

View →